About GCSA
GCSA’s “right first time” and “quality built in” ethos facilitates process excellence and seamless collaboration between sponsors, CROs and clinical trial sites.
GCSA Demonstrates Commitment to Quality
Commitment to the GCSA journey demonstrates dedication to quality, the desire for ensuring high-quality patient experience, and the aspiration to be a clinical trial site of choice.
Distinctive certification marks are awarded on a modular basis, evidencing that participating sites have met rigorous, independently-assessed quality standards.
Our
Ambition
GCSA’s ambition is to play a significant role in creating a clinical research ecosystem, shaping the future of healthcare and improving people’s lives around the world.
Expediting Best Practice Sharing
GCSA facilitates networking to expedite best practice sharing and innovation through it’s Global Advisory Board, Taskforces, education and development activities and Think Tanks.
Our forward thinking sites
Founding Members of the
GCSA Global Advisory Board
Elizabeth Edwards
Biomat USA
Samin Saeed
Novartis / ABPI Representative
John Mellelieu
Pfizer
Teresa Allen
HRA (Health Research Authority)
Janet Messer
HRA (Health Research Authority)
Sandra Johnson
MMV (Medicines for Malaria Venture)
Maria Palmer
NHS R&D Forum
Simon Lewis
NHS – London North West University Healthcare
Emer MacSweeney
Re:Cognition Health
Agnieszka Gackowska
Parexel
Karen McIntyre
Syneos Health
A global quality standard for clinical trial sites developed with a Global Advisory Board of stakeholders from across the clinical research industry.
+44 (0)1628 784906 (UK HQ)
+1 (855) 209 2335 (US Toll Free)
